Ki-67 and CEA expression as prognostic markers in Dukes' C colorectal cancer

This publication has 11 references indexed in Scilit:

• DNA Ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study
  Zeitschrift für Krebsforschung und Klinische Onkologie, 2002
• The Relationship between the Number of Metastatic Lymph Nodes and Prognosis of Patients with Dukes C Colon Cancer
  The Japanese Journal of Gastroenterological Surgery, 2002
• Relevance of Ki-67 antigen expression and K- ras mutation in colorectal liver metastases
  European Journal of Surgical Oncology, 2001
• The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas
  Surgery Today, 1999
• FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas
  British Journal of Cancer, 1999
• Ki‐67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinomas
  APMIS, 1997
• Determination of proliferative activity in colorectal carcinoma using monoclonal antibody Ki67
  Diseases of the Colon & Rectum, 1997
• Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: Analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling
  International Journal of Cancer, 1996
• An evaluation of five different methods for estimating proliferation in human colorectal adenocarcinomas
  Surgical Oncology, 1994
• Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma: A multivariate analysis
  Cancer, 1992